GRT3983Y

· Grünenthal GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GRT3983Y, covering 2012-05-03 to 2012-05-03. Get the full timeline:

Most recent: Clinical Trial Update: A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y [Phase 2]